Celegence Acquires Qdossier To Bolster Its Regulatory Consultancy Services And Solutions For The Pharmaceutical Industry
Celegence Acquires Qdossier To Bolster Its Regulatory Consultancy Services And Solutions For The Pharmaceutical Industry
07/18/22, 8:08 AM
Industry
media and entertainment
software
manufacturing
software
Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has today announced the acquisition of Qdossier, a supplier of end-to-end services to support document and dossier lifecycle management for pharmaceutical products. Qdossier also provides leading cloud-based technology, which creates transparency, consistency, and reusability across regulatory dossiers.
Company Info
Company info
Celegence helps life sciences companies navigate complex global regulatory requirements by providing consulting services and solutions dedicated to regulatory affairs. Celegence supports life science customers in the areas of EU MDR compliance, IVDR compliance, regulatory intelligence, RIMS data management, publishing, regulatory labeling including UDI consulting, and medical writing. Celegence's depth of experience and extensive delivery capabilities allow regulatory affairs and quality teams to operate more efficiently, reduce cost, and improve compliance. For more information, visit www.celegence.com or follow Celegence on LinkedIn.